Enliven Therapeutics, Inc. Share Price
ELVN$0.00
+0.00 (0.00%) Enliven Therapeutics, Inc. Stock Performance
Open N/A | Prev. Close N/A | Circuit Range N/A |
Day Range N/A | Year Range N/A | Volume N/A |
Average Traded N/A |
Enliven Therapeutics, Inc. Share Price Chart
$0.00
Please wait...
About Enliven Therapeutics, Inc.
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead product candidates comprise ELVN-001, a small molecule kinase inhibitor which is in Phase 1 clinical trial to treat adults with chronic myeloid leukemia; and ELVN-002, a CNS penetrant and irreversible HER2 inhibitor that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer (NSCLC) and other HER2 driven cancers and solid tumors. The company is headquartered in Boulder, Colorado.
Enliven Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|
FAQs on Enliven Therapeutics, Inc. Share Price
Can I buy Enliven Therapeutics, Inc. shares in India?
Yes. You can buy Enliven Therapeutics, Inc. in India by opening an international trading account.
What is the share price of Enliven Therapeutics, Inc.?
As on 01 Mar '26, the share price of Enliven Therapeutics, Inc. ELVN is $0.00. If you are investing from India, it is a good idea to check the current exchange rate and calculate the value in rupees before making your investment.
What is the 5 year returns of Enliven Therapeutics, Inc.?
The 5 year returns of Enliven Therapeutics, Inc. is as on 01 Mar '26.
What are the high & low stock price of Enliven Therapeutics, Inc. today?
Enliven Therapeutics, Inc. stock price hit a high of $0.00 and low of $0.00 as on 01 Mar '26.
What is the 52-week high and low of Enliven Therapeutics, Inc. stock?
The 52-week high of Enliven Therapeutics, Inc. stock is $0.00, while the 52-week low is $0.00 as on 01 Mar '26.